Beyond the bladder: case series of Mycobacterium bovis bacillus Calmette-Guérin infections following intravesical instillation
Abstract
Intravesical instillation of Mycobacterium bovis bacillus Calmette-Guérin (BCG) was first used to treat bladder cancer in 1976. Since then, it has become a common therapy for non-muscle invasive bladder cancer. A live, attenuated mycobacterium, M. bovis BCG causes infectious complications in approximately 1% of patients. These infections can involve various anatomic sites and have a range of presentations. Diagnosis may require several testing modalities, and treatment typically involves multiple antimicrobials for a long duration. We report three cases of M. bovis BCG infection following intravesical BCG instillation for the treatment of bladder cancer. The patients are men ranging in age from 71 to 83 years old. One had a ruptured mycotic aneurysm of the aorta, another had a presumed anaphylactic reaction, and the final had a bone marrow infection. Isolation of BCG was achieved through mycobacterial blood culture in two cases and also through mycobacterial culture of bone marrow and hematoma aspirate. Nucleic acid amplification testing for Mycobacterium tuberculosis complex (of which BCG is a member) was utilized in two cases, and histologic examination identified granulomas in one case. Two of the patients received mycobacterial treatment, including rifampin, isoniazid, ethambutol, and linezolid. One patient remains living over 3 years after infection, one died despite treatment, and one died from unrelated causes. These cases highlight the diversity of BCG infection…
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.